MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-11-0008497
Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited - trading in Uttamnagar, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.76 Lakh
▼ 7% YoY
Net loss · FY 2025
₹3.8 Lakh
Net margin -9.6%
EBITDA · FY 2025
-₹3.24 Lakh
EBITDA margin -8.2%
Authorised capital
₹6 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Axonwave Pharmaceuticals Private Limited
Data last updated:
Axonwave Pharmaceuticals Private Limited is a private limited company based in Uttamnagar, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC372134. Its GSTIN is 07AAUCA2734Q1ZY (Delhi).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Ananya Bhasin and Kanchan Banga.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 178 Kh No.117 Vipin Garden Extn., Uttamnagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.76 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹3.8 Lakh (net margin -9.6%) and EBITDA of -₹3.24 Lakh (EBITDA margin -8.2%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
Axonwave Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0008497).
Company details
CIN U51909DL2020PTC372134
Registration Number 372134
Incorporation Date 24 October 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0008497
Recognitions & Rankings of Axonwave Pharmaceuticals
Contact details
Axonwave Pharmaceuticals Private Limited's registered office is in Uttamnagar, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 178 Kh No.117 Vipin Garden Extn., Uttamnagar, Delhi, India – 110059
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Axonwave Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Axonwave Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Axonwave Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Axonwave Pharmaceuticals Private Limited, buy the company report.
Financials of Axonwave Pharmaceuticals Private Limited
FY 2025 filings availableAxonwave Pharmaceuticals Private Limited reported revenue of ₹39.76 Lakh (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹39.76 Lakh ▼ 7%
Net loss · FY 2025
₹3.8 Lakh margin -9.6%
EBITDA · FY 2025
-₹3.24 Lakh margin -8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 505%
3 years · compounded
▼ 83%
Revenue has declined at a compounded annual rate (CAGR) of 14% over three years, including a 7% fall in the latest year. EBITDA fell 505% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | ||||
| Net Profit Margin | -9.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axonwave Pharmaceuticals Private Limited, buy the company report.
Board of directors of Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ananya Bhasin Also directs: Aass Pharma Private Limited | Director | 02 Apr 2021 | 5 Years 6 Months | Current |
| Kanchan Banga | Director | 02 Apr 2021 | 5 Years 6 Months | Current |
| Prashant Kumar | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
| Neha Chanana | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
| Pramila Gupta Also directs: Delhi Epilepsy and Stroke Foundation | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Axonwave Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axonwave Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Axonwave Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Axonwave Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAUCA2734Q1ZY | Delhi | Active | 10 Nov 2020 |
To see the full GST registrations and return filing status of Axonwave Pharmaceuticals Private Limited, buy the company report.
Recent activity
Axonwave Pharmaceuticals Private Limited has 5 board changes on record since 2020: 5 appointments. The latest: Ananya Bhasin was appointed as Director on 02 Apr 2021.
AGM
Axonwave Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Axonwave Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Ananya Bhasin was appointed as Director.
Appointed
Kanchan Banga was appointed as Director.
Appointed
Neha Chanana was appointed as Director.
Appointed
Pramila Gupta was appointed as Director.
Appointed
Prashant Kumar was appointed as Director.
Incorporation
24 Oct 2020
Axonwave Pharmaceuticals Private Limited was registered on 24 Oct 2020 with Roc Delhi Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Axonwave Pharmaceuticals is an active private limited company based in Uttamnagar, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 24 October 2020 (6+ years old) and is registered under CIN U51909DL2020PTC372134.
Axonwave Pharmaceuticals has 5 current directors:
- Ananya Bhasin - Director
- Kanchan Banga - Director
- Prashant Kumar - Director
- Neha Chanana - Director
- Pramila Gupta - Director
The latest financial statements of Axonwave Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Axonwave Pharmaceuticals is 07AAUCA2734Q1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Axonwave Pharmaceuticals is U51909DL2020PTC372134. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axonwave Pharmaceuticals was incorporated on 24 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Ananya Bhasin was appointed as Director on 02 Apr 2021. Kanchan Banga was appointed as Director on 02 Apr 2021. Neha Chanana was appointed as Director on 24 Oct 2020. Axonwave Pharmaceuticals has 5 board changes on record in total.
Yes, Axonwave Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0008497).
The registered office of Axonwave Pharmaceuticals is at Plot No. 178 Kh No.117 Vipin Garden Extn., Uttamnagar, Delhi, India – 110059.
Axonwave Pharmaceuticals operates in the trading industry, in the specialty segment.